Yasmin K Hilliam (Yasmin Hilliam)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Pseudomonas Aeruginosa

Biofilm Formation

Cystic Fibrosis

Top Venues

Microbiology spectrum

Journal of bacteriology

This page only lists publications with an associated author ORCID identifier.

Publications

Catherine R Armbruster, Yasmin K Hilliam, Anna C Zemke, Samar Atteih, Christopher W Marshall, John Moore, Junu Koirala, Leah Krainz, Jordan R Gaston, Stella E Lee, Vaughn S Cooper, Jennifer M Bomberger
Persistence and evolution of Pseudomonas aeruginosa following initiation of highly effective modulator therapy in cystic fibrosis. mBio 15 (5) (2024)
Yasmin K Hilliam, Catherine R Armbruster, Glenn J Rapsinski, Christopher W Marshall, John Moore, Junu Koirala, Leah Krainz, Jordan R Gaston, Vaughn S Cooper, Stella E Lee, Jennifer M Bomberger
Cystic fibrosis pathogens persist in the upper respiratory tract following initiation of elexacaftor/tezacaftor/ivacaftor therapy. Microbiology spectrum 12 (8) (2024)
Yasmin K Hilliam, Catherine R Armbruster, Glenn J Rapsinski, Christopher W Marshall, John Moore, Junu Koirala, Leah Krainz, Jordan R Gaston, Vaughn S Cooper, Stella E Lee, Jennifer M Bomberger
Cystic fibrosis pathogens persist in the upper respiratory tract following initiation of elexacaftor/tezacaftor/ivacaftor therapy. Microbiology spectrum (2024)
Yasmin K Hilliam, Catherine R Armbruster, Glenn J Rapsinski, Christopher W Marshall, John Moore, Junu Koirala, Leah Krainz, Jordan R Gaston, Vaughn S Cooper, Stella E Lee, Jennifer M Bomberger
Cystic fibrosis pathogens persist in the upper respiratory tract following initiation of elexacaftor/tezacaftor/ivacaftor therapy. Microbiology spectrum 12 (8) (2024)
Catherine R Armbruster, Yasmin K Hilliam, Anna C Zemke, Samar Atteih, Christopher W Marshall, John Moore, Junu Koirala, Leah Krainz, Jordan R Gaston, Stella E Lee, Vaughn S Cooper, Jennifer M Bomberger
Persistence and evolution of Pseudomonas aeruginosa following initiation of highly effective modulator therapy in cystic fibrosis. mBio (2024)
Catherine R Armbruster, Yasmin K Hilliam, Anna C Zemke, Samar Atteih, Christopher W Marshall, John Moore, Junu Koirala, Leah Krainz, Jordan R Gaston, Stella E Lee, Vaughn S Cooper, Jennifer M Bomberger
Persistence and evolution of Pseudomonas aeruginosa following initiation of highly effective modulator therapy in cystic fibrosis. mBio 15 (5) (2024)
Yasmin K Hilliam, Catherine R Armbruster, Glenn J Rapsinski, Christopher W Marshall, John Moore, Junu Koirala, Leah Krainz, Jordan R Gaston, Vaughn S Cooper, Stella E Lee, Jennifer M Bomberger
Cystic fibrosis pathogens persist in the upper respiratory tract following initiation of elexacaftor/tezacaftor/ivacaftor therapy. Microbiology spectrum (2024)
Catherine R Armbruster, Yasmin K Hilliam, Anna C Zemke, Samar Atteih, Christopher W Marshall, John Moore, Junu Koirala, Leah Krainz, Jordan R Gaston, Stella E Lee, Vaughn S Cooper, Jennifer M Bomberger
Persistence and evolution of Pseudomonas aeruginosa following initiation of highly effective modulator therapy in cystic fibrosis. mBio 15 (5) (2024)
Sidney Lane, Yasmin K Hilliam, Jennifer M Bomberger
Microbial and Immune Regulation of the Gut-Lung Axis during Viral-Bacterial Coinfection. Journal of bacteriology (2022)